{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:49:00Z","timestamp":1787024940097,"version":"build-2736575974"},"reference-count":14,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"consulting or advisory role"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.2217\/fon-2022-1059","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:19:07Z","timestamp":1715962747000},"page":"123-135","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["TRUST-II: a global phase II study of taletrectinib in\n                    <i>ROS1<\/i>\n                    -positive non-small-cell lung cancer and other solid tumors"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-615X","authenticated-orcid":false,"given":"Misako","family":"Nagasaka","sequence":"first","affiliation":[{"name":"University of California Irvine School of Medicine,\rOrange,\rCA,\rUSA"},{"name":"Chao Family Comprehensive Cancer Center,\rOrange,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-073X","authenticated-orcid":false,"given":"Yuichiro","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department ofThoracic Oncology,National Cancer Center Hospital,\rTokyo,\rJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,Shanghai Pulmonary Hospital,Tongji University School of Medicine,\rShanghai,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-min","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine,Asan Medical Center,University of Ulsan College of Medicine,\rSeoul,\rRepublic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-3645","authenticated-orcid":false,"given":"Nong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,Hunan Cancer Hospital,Xiangya School of Medicine,Central South University,\rChangsha,\rChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology,Princess Margaret Cancer Centre,University Health Network,\rToronto,\rCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7620-0098","authenticated-orcid":false,"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron Institute of Oncology,Vall d\u2019Hebron University Hospital,\rBarcelona,\rSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"P\u00e9rol","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology,L\u00e9on B\u00e9rard Cancer Center,\rLyon,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-8189","authenticated-orcid":false,"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine,Gustave Roussy Cancer Centre, Villejuif, France;Paris-Saclay University,\rOrsay,\rFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1605-4719","authenticated-orcid":false,"given":"Jorge","family":"Nieva","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology,Norris Comprehensive Cancer Center,University of Southern California,\rLos Angeles,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2669-5771","authenticated-orcid":false,"given":"Luis","family":"Raez","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Program,Memorial Cancer Institute\/Memorial Health Care System,Florida Atlantic University,\rMiami,\rFL,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-0064","authenticated-orcid":false,"given":"Nathan A","family":"Pennell","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Taussig Cancer Center,\rCleveland,\rOH,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-3305","authenticated-orcid":false,"given":"Anastasios","family":"Dimou","sequence":"additional","affiliation":[{"name":"Department of Oncology,Mayo Clinic,\rRochester,\rMN,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo de","family":"Marinis","sequence":"additional","affiliation":[{"name":"European Institute of Oncology,\rIRCCS,\rMilan,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine,Division of Medical Oncology,University of Campania Luigi Vanvitelli,\rNaples,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2960-4364","authenticated-orcid":false,"given":"Takashi","family":"Seto","sequence":"additional","affiliation":[{"name":"Precision Medicine Asia (PREMIA) Co. Ltd,\rTokyo,\rJapan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Hu","sequence":"additional","affiliation":[{"name":"AnHeart Therapeutics,\rNY,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Pan","sequence":"additional","affiliation":[{"name":"AnHeart Therapeutics,\rNY,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[{"name":"AnHeart Therapeutics,\rNY,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanglian","family":"Li","sequence":"additional","affiliation":[{"name":"AnHeart Therapeutics,\rNY,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-4975","authenticated-orcid":false,"given":"Sai-Hong I","family":"Ou","sequence":"additional","affiliation":[{"name":"University of California Irvine School of Medicine,\rOrange,\rCA,\rUSA"},{"name":"Chao Family Comprehensive Cancer Center,\rOrange,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"issue":"3","key":"e_1_3_6_3_1","first-page":"254","article-title":"NCCN Guidelines Insights: Non-Small Cell Lung Cancer, version 2.2021","volume":"19","author":"Ettinger DS","year":"2021","unstructured":"Ettinger DS , WoodDE, AisnerDLet al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, version 2.2021. J. NatlCompr. Canc. Netw.19(3), 254\u2013266 (2021).","journal-title":"J. Natl"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406766"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.5587"},{"key":"e_1_3_6_6_1","first-page":"PO.17.00063","article-title":"Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small-cell lung cancer","volume":"2017","author":"Gainor JF","year":"2017","unstructured":"Gainor JF , TsengD, YodaSet al. Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small-cell lung cancer. JCO Precis. Oncol.2017, PO.17.00063 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30655-2"},{"issue":"6","key":"e_1_3_6_8_1","first-page":"100332","article-title":"Long-term efficacy and safety of entrectinib in ROS1 fusion-positive NSCLC","volume":"3","author":"Drilon A","year":"2022","unstructured":"Drilon A , ChiuC-H, FanYet al. Long-term efficacy and safety of entrectinib in ROS1 fusion-positive NSCLC. JTO Clin. Res. Rep.3(6), 100332 (2022).","journal-title":"JTO Clin. Res. Rep."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/LCTT.S190786"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11496-z"},{"key":"e_1_3_6_11_1","unstructured":"ROZLYTREK United States prescribing information (2021). www.gene.com\/download\/pdf\/rozlytrek_prescribing.pdf"},{"key":"e_1_3_6_12_1","volume-title":"34th EORTC-NCI-AACR Symposium.","author":"Cho B C","year":"2022","unstructured":"Cho B C , LinJ, CamidgeD R et al. Pivotal topline data from the phase 1\/2 TRIDENT-1 trial of repotrectinibin patients with ROS1+ advanced non-small cell lung cancer (NSCLC). Presented at: 34th EORTC-NCI-AACR Symposium. (2022)."},{"issue":"16","key":"e_1_3_6_13_1","first-page":"8572","article-title":"TRUST: the efficacy and safety of taletrectinib in TKI-naive or crizotinib-pretreated ROS1-positive non-small cell lung cancer (NSCLC) patients","volume":"40","author":"Li W","unstructured":"Li W , YangN, LiKet al. TRUST: the efficacy and safety of taletrectinib in TKI-naive or crizotinib-pretreated ROS1-positive non-small cell lung cancer (NSCLC) patients. J. Clin. Oncol.40(Suppl. 16), 8572\u20138572 (Poster ASCO 2022). www.anhearttherapeutics.com\/file.cfm\/14\/docs\/2022_asco_c203_poster.pdf","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"e_1_3_6_14_1","first-page":"100108","article-title":"Efficacy of taletrectinib (AB-106\/DS-6051b) in ROS1+ NSCLC: an updated pooled analysis of US and Japan phase 1 studies","volume":"2","author":"Ou S-HI","year":"2021","unstructured":"Ou S-HI , FujiwaraY, ShawATet al. Efficacy of taletrectinib (AB-106\/DS-6051b) in ROS1+ NSCLC: an updated pooled analysis of US and Japan phase 1 studies. JTO Clin. Res. Rep.2(1), 100108 (2021).","journal-title":"JTO Clin. Res. Rep."},{"key":"e_1_3_6_15_1","unstructured":"Xalkori United States prescribing information. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/202570s033lbl.pdf"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00505"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2022-1059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:48:11Z","timestamp":1719110891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2022-1059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.2217\/fon-2022-1059"],"URL":"https:\/\/doi.org\/10.2217\/fon-2022-1059","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}